AAAAAA
Results:
1-13
|
Results: 13
Authors:
Sabri, F
De Milito, A
Pirskanen, R
Elovaara, I
Hagberg, L
Cinque, P
Price, R
Chiodi, F
Citation: F. Sabri et al., Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex, J NEUROIMM, 114(1-2), 2001, pp. 197-206
Authors:
Peltola, J
Ukkonen, M
Moilanen, E
Elovaara, I
Citation: J. Peltola et al., Increased nitric oxide products in CSF in primary progressive MS may reflect brain atrophy, NEUROLOGY, 57(5), 2001, pp. 895-896
Authors:
Mattila, KM
Luomala, M
Lehtimaki, T
Laippala, P
Koivula, T
Elovaara, I
Citation: Km. Mattila et al., Interaction between ESR1 and HLA-DR2 may contribute to the development of MS in women, NEUROLOGY, 56(9), 2001, pp. 1246-1247
Authors:
Luomala, M
Elovaara, I
Ukkonen, M
Koivula, T
Lehtimaki, T
Citation: M. Luomala et al., The combination of HLA-DR1 and HLA-DR53 protects against MS, NEUROLOGY, 56(3), 2001, pp. 383-385
Authors:
Luomala, M
Lehtimaki, T
Elovaara, I
Wang, XY
Ukkonen, M
Mattila, K
Laippala, P
Koivula, T
Hurme, M
Citation: M. Luomala et al., A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis, J NEUR SCI, 185(2), 2001, pp. 123-127
Authors:
Luomala, M
Elovaara, I
Koivula, T
Lehtimaki, T
Citation: M. Luomala et al., Intracellular adhesion molecule-1 polymorphisms and genetic susceptibilityto multiple sclerosis: Additional data and meta-analysis - Reply, ANN NEUROL, 47(2), 2000, pp. 278-279
Authors:
Luomala, M
Elovaara, I
Ukkonen, M
Koivula, T
Lehtimaki, T
Citation: M. Luomala et al., Plasminogen activator inhibitor 1 gene and risk of MS in women, NEUROLOGY, 54(9), 2000, pp. 1862-1864
Adhesion molecules in multiple sclerosis - Relation to subtypes of diseasemethylprednisolone therapy
Authors:
Elovaara, I
Ukkonen, M
Leppakynnas, M
Lehtimaki, T
Luomala, M
Peltola, J
Dastidar, P
Citation: I. Elovaara et al., Adhesion molecules in multiple sclerosis - Relation to subtypes of diseasemethylprednisolone therapy, ARCH NEUROL, 57(4), 2000, pp. 546-551
Authors:
Luomala, M
Elovaara, I
Koivula, T
Lehtimaki, T
Citation: M. Luomala et al., Intercellular adhesion molecule-1 K/E 469 polymorphism and multiple sclerosis, ANN NEUROL, 45(4), 1999, pp. 546-546
Authors:
Dastidar, P
Heinonen, T
Vahvelainen, T
Elovaara, I
Eskola, H
Citation: P. Dastidar et al., Computerised volumetric analysis of lesions in multiple sclerosis using new semi-automatic segmentation software, MED BIO E C, 37(1), 1999, pp. 104-107
Authors:
Dastidar, P
Heinonen, T
Lehtimaki, T
Ukkonen, M
Peltola, J
Erila, T
Laasonen, E
Elovaara, I
Citation: P. Dastidar et al., Volumes of brain atrophy and plaques correlated with neurological disability in secondary progressive multiple sclerosis, J NEUR SCI, 165(1), 1999, pp. 36-42
Authors:
Elovaara, I
Sabri, F
Gray, F
Alafuzoff, I
Chiodi, F
Citation: I. Elovaara et al., Upregulated expression of Fas and Fas ligand in brain through the spectrumof HIV-1 infection, ACT NEUROP, 98(4), 1999, pp. 355-362
Authors:
Elovaara, I
Lalla, M
Spare, E
Lehtimaki, T
Dastidar, P
Citation: I. Elovaara et al., Methylprednisolone reduces adhesion molecules in blood and cerebrospinal fluid in patients with MS, NEUROLOGY, 51(6), 1998, pp. 1703-1708
Risultati:
1-13
|